Re: [#DIV28SUPER] Division 28 Award Winners!

Let’s try that one more time!  2017 award winners!

 

Catherine Stanger, Ph.D.

Associate Professor

Center for Technology and Behavioral Health

Geisel School of Medicine at Dartmouth

Dartmouth College

46 Centerra Parkway

EverGreen Center Suite 300

Suite 300, HB 7255

Lebanon, NH 03766

Catherine.stanger@dartmouth.edu

Phone 603-646-7023

Fax 603-448-5335

www.c4tbh.org

 

From: Catherine Stanger
Sent: Tuesday, January 31, 2017 9:20 AM
To: DIV28SUPER@LISTS.APA.ORG
Subject: Division 28 Award Winners!

 

Please join me in congratulating our 2016 Division 28 Award Winners!  We had many excellent candidates nominated in all three categories, and I would like to thank all the nominees and those who nominated them for their participation this year.  Division 28 has an outstanding roster of early career and senior scientists doing excellent work.

Now, for our winners.

 

MED Associates Brady-Schuster Award honors a mid-career or senior scientist (at least 15 years after doctoral degree) who conducts outstanding research underscoring the fundamental importance of behavioral science to psychopharmacology or substance abuse.

This year’s winner is Dorothy Hatsukami, Ph.D. Dr. Hatsukami is Professor of Psychiatry at the University of Minnesota.  Minnesota takes it 2 years in a row! Go Golden Gophers!

 

Young Psychopharmacologist Award honors a young scientist conducting original, meritorious work in psychopharmacology and encourages excellence in research at the interface between the disciplines of pharmacology and psychology.

This year’s winner is James Mahoney, Ph.D.  Dr. Mahoney is Assistant Professor in the Department of Behavioral Medicine and Psychiatry, West Virginia University School of Medicine.

 

Outstanding Dissertation Award honors the best doctoral dissertation in psychopharmacology and substance abuse. 

This year’s winner is Elizabeth Holly, Ph.D.  Dr. Holly completed her Ph.D. in Experimental Psychology in 2015 at Tufts University, and she is currently a postdoctoral fellow in the Department of Neuroscience at the University of Pennsylvania Perelman School of Medicine.

 

Congratulations to all, and we look forward to your presentations in Washington!

 

Regards,

Cathy Stanger

Division 28 Awards Chair

 

 

Catherine Stanger, Ph.D.

Associate Professor

Center for Technology and Behavioral Health

Geisel School of Medicine at Dartmouth

Dartmouth College

46 Centerra Parkway

EverGreen Center Suite 300

Suite 300, HB 7255

Lebanon, NH 03766

Catherine.stanger@dartmouth.edu

Phone 603-646-7023

Fax 603-448-5335

www.c4tbh.org

 

[#DIV28SUPER] Division 28 Award Winners!

Please join me in congratulating our 2016 Division 28 Award Winners!  We had many excellent candidates nominated in all three categories, and I would like to thank all the nominees and those who nominated them for their participation this year.  Division 28 has an outstanding roster of early career and senior scientists doing excellent work.

Now, for our winners.

 

MED Associates Brady-Schuster Award honors a mid-career or senior scientist (at least 15 years after doctoral degree) who conducts outstanding research underscoring the fundamental importance of behavioral science to psychopharmacology or substance abuse.

This year’s winner is Dorothy Hatsukami, Ph.D. Dr. Hatsukami is Professor of Psychiatry at the University of Minnesota.  Minnesota takes it 2 years in a row! Go Golden Gophers!

 

Young Psychopharmacologist Award honors a young scientist conducting original, meritorious work in psychopharmacology and encourages excellence in research at the interface between the disciplines of pharmacology and psychology.

This year’s winner is James Mahoney, Ph.D.  Dr. Mahoney is Assistant Professor in the Department of Behavioral Medicine and Psychiatry, West Virginia University School of Medicine.

 

Outstanding Dissertation Award honors the best doctoral dissertation in psychopharmacology and substance abuse. 

This year’s winner is Elizabeth Holly, Ph.D.  Dr. Holly completed her Ph.D. in Experimental Psychology in 2015 at Tufts University, and she is currently a postdoctoral fellow in the Department of Neuroscience at the University of Pennsylvania Perelman School of Medicine.

 

Congratulations to all, and we look forward to your presentations in Washington!

 

Regards,

Cathy Stanger

Division 28 Awards Chair

 

 

Catherine Stanger, Ph.D.

Associate Professor

Center for Technology and Behavioral Health

Geisel School of Medicine at Dartmouth

Dartmouth College

46 Centerra Parkway

EverGreen Center Suite 300

Suite 300, HB 7255

Lebanon, NH 03766

Catherine.stanger@dartmouth.edu

Phone 603-646-7023

Fax 603-448-5335

www.c4tbh.org

 

[#DIV28SUPER] Cluster of an Unusual Amnestic Syndrome — Massachusetts, 2012–2016

Tragedies like this sometimes lead to new research tools like MPTP.. if in fact this is attributable to a novel toxicant on the street.  Psychologists should be alert to presentations with striking sudden onset amnesia presentations in their hospitals or clinics:

"...MRI of the head, toxicology screening, and neurologic consultation should be considered in all adults aged ≥18 years with sudden-onset amnesia, particularly in patients with altered consciousness. Advanced laboratory testing, including testing for synthetic opioids (e.g., fentanyl) and their analogues, as well as extraneous substances not assessed in these reported cases, might further clarify an association with substance use..."

Barash JA, Somerville N, DeMaria A Jr.. Cluster of an Unusual Amnestic Syndrome — Massachusetts, 2012–2016. MMWR Morb Mortal Wkly Rep 2017;66:76–79. DOI: http://dx.doi.org/10.15585/mmwr.mm6603a2

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] Postdoctoral fellowship

T32 POSTDOCTORAL POSITIONS

Co-Occurring Substance Use and Mental Health Disorders

Geisel School of Medicine at Dartmouth

 

The Geisel School of Medicine at Dartmouth offers a unique postdoctoral training program in a developing area of transdisciplinary/translational research, co-occurring substance use and other mental disorders (COD) http://geiselmed.dartmouth.edu/scd/.  Applicants interested in smoking, electronic cigarettes, and technology-delivered interventions are encouraged to apply.

The philosophy of this program asserts that to effectively impact the problems of addiction and mental illness, one must be fully aware of their co-existence, etiologies, phenomenology, and clinical manifestations. Moreover, knowledge of integrated clinical approaches and the healthcare systems that serve those with co-occurring disorders are necessary to inform the questions to be asked in laboratory, animal and human imaging and clinical research studies. At Dartmouth, six interconnected groups from neuroscience through implementation research, and across multiple departments provide research opportunities in social, behavioral, neurobiological mechanisms, treatment development (psychosocial and pharmacological), technology-assisted treatment and dissemination, and health services  and implementation. Faculty include preeminent national/international leaders in COD, Technology and Behavioral Health, Cannabis/Marijuana, behavioral and pharmacological interventions for addiction, schizophrenia and substance use, impact of media on substance use.  Faculty include PhD and MD investigators with strong histories of training scientists, and a team of support faculty committed to establishing a structured training program in COD. Research teams include neuroscientists, psychopharmacologists, behavioral health technologists, clinical trials and contingency management experts, health services researchers, anthropologists, statisticians, economists, and clinicians. Program faculty lead diverse projects funded by many NIH institutes (NIDA, NIAAA, NIMH, NCI, NCATS and NICHD), and also multiple foundation, Department of Education, and VA supported studies. 

 

Appointment:  Typically 2-3 yrs.  Eligibility: Applicants must have completed their training in psychology, or a related discipline and be U.S. citizens or permanent residents.   Trainees are selected on the basis of scholastic record and commitment to a career in co-occurring disorders research.  Benefits: Stipend, medical insurance coverage, and travel funds supported by NIH Institutional Training Awards.  For more information:  Contact Dr. Sarah Pratt (sarah.i.pratt@dartmouth.edu), Dr. Mary Brunette (mary.f.brunette@dartmouth.edu), or Dr. Alan Budney (alan.budney@dartmouth.edu).  To apply: Forward curriculum vitae, statement of research interests, and 3 letters of reference to Brian Goodness, Operations Assistant (Brian.D.Goodness@dartmouth.edu). 

 

 

Alan Budney, Ph.D.

Geisel School of Medicine at Dartmouth

Department of Psychiatry

One Medical Center Drive, HB 7459

Lebanon, NH  03756

Email: alan.j.budney@dartmouth.edu

 

[#DIV28SUPER] Collaborative Perspectives on Addiction meeting March 24-25, 2017

Conference Registration

 

The scientific program includes 2 keynote addresses from leaders in the field, 15 symposia, over 80 poster presentations and two days of clinical skill-building opportunities!

 

Two days of clinical skill-building opportunities!

Mini-workshop #1: Emotion Regulation Training: Helping Clients to Manage Negative Emotions
Presented by Clara M. Bradizza, PhD, Kim Slosman, MS, & Paul R. Stasiewicz, PhD, University at Buffalo. This introductory workshop on Emotion Regulation Training (ERT) will review the ERT intervention, describe its basic components and provide a step-by-step guide on implementing core therapeutic principles of ERT.

 

Mini-Workshop #2: Cognitive Behavior Therapy for Alcohol and Drug

Problems: An Introductory Workshop

Presented by Barbara McCrady, PhD, University of New Mexico. The goal of this workshop is to provide an overview of the CBT approach and basic skills in CBT. The workshop will use active learning techniques and application of workshop material to sample cases.

 

Mini-Workshop #3: Treating Suicidal Thoughts and Behaviors in Adults with Substance Use Disorders (SUDs)

Presented by Mark Ilgen, PhD & Erin Goldman, LMSW, University of Michigan. This workshop will review the cognitive behavioral model for suicidal thoughts and provide descriptions of techniques to specifically target suicidal thoughts and behaviors among those with SUDs.

 

Mini-Workshop #4: Screening, Brief Intervention, and Referral to Treatment: SBIRT in Diverse Practice Settings

Presented by Jessica L. Martin, PhD, M. Dolores Cimini, PhD, & Laura Longo, MS, University at Albany. This workshop will present cutting-edge research and training on integrating screening, brief intervention, and referral to treatment in primary health and mental health care settings.

 

Mini-Workshop #5: Drug Use, Misuse, and Abuse: A Workshop on Recent Advances in Psychopharmacology

Presented by Cecile A. Marczinski, PhD, Northern Kentucky University. The purpose of this workshop is to provide a general audience with an overview of how recreational drugs

affect the brain and behavior and can lead to addiction. In addition, the current medications being used to effectively treat addiction will be highlighted.

 

Up to 12 credits of Continuing Education will be available!  Please visit our website for more information.

[#DIV28SUPER] Seeking Nominees for Division 28 President (2019), Council Rep, and Member-at-Large

Hello all,

I would like to ask your help in identifying potential nominees for the above referenced elected positions.  The position of Division president is a one year term for the 2019 calendar year, preceded by a year on the executive committee as President elect and followed by a year as past-president.  The term for the Council Representative is three years as is that of the Member-at-Large. Nominees for President and Council Representative must have Fellow status, but nominees for Member-at-Large do not.

I greatly appreciate your assistance in identifying qualified nominees for these positions. With your help we will continue to have a stellar executive committee to maintain the important contributions made by our Division.

Sincerely,

David S. Festinger, Ph.D.

2017 President

APA Division of Psychopharmacology and Substance Abuse

PCOM provides email capability to all students, faculty, staff, and administration.  All emails and attached files transmitted between and among the foregoing are considered confidential. The emails and attached files are intended solely for the use of the individual or entity to which they are addressed and reading, disclosing, disseminating, distributing or copying by a recipient other than that named therein is strictly prohibited. Any email described herein that is received by an entity or individual to which it is not specifically addressed should be immediately deleted by the unnamed recipient.

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] CIA documents expose internal agency feud over psychologists leading interrogation program

A strong argument for why it is essential to have psychologists inside our national security apparatus.

https://www.washingtonpost.com/world/national-security/cia-documents-expose-internal-agency-feud-over-psychologists-leading-interrogation-program/2017/01/18/a73bd722-dd85-11e6-918c-99ede3c8cafa_story.html?wpisrc=al_alert-COMBO-world%252Bnation


Sent from my iPhone
_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

[#DIV28SUPER] Fwd: Science News Update - Sen. Flake responds to APA advocate about federal research funding

Sent from my iPhone

Begin forwarded message:

From: "Waldroff, Kirk" <kwaldroff@apa.org>
Date: January 13, 2017 at 1:43:01 PM EST
To: "Waldroff, Kirk" <kwaldroff@apa.org>
Subject: Science News Update - Sen. Flake responds to APA advocate about federal research funding

Hello, please share this important news update with your division…

 

**********

 

APA Science Government Relations News Update:

Sen. Flake responds to APA advocate about federal research funding

Recorded exchange captures controversy over "wastebooks"

 

Sen. Jeff Flake (R-AZ) announced the release of his latest "wastebook" at a Washington press conference on Jan. 10, 2017.   The document - titled "Porkemon Go" - lists what Flake believes to be examples of wasteful government spending, including federally funded research projects.

 

At the press conference, Pat Kobor of the American Psychological Association's Science Government Relations Office, raised the concern that such wastebooks misrepresent the research supported by the National Institutes of Health and other federal agencies.  Together, Kobor's comments and Flake's response capture much of the current debate surrounding wastebooks - a debate that may become more heated as Congress and the new administration proceed with budget deliberations this year.

 

Watch the video. 

 

 

 

 

 

 

Kirk Waldroff | Director of Communications Science Directorate | (202)336-6192 | kwaldroff@apa.org  American Psychological Association www.apa.org | @apascience   Advancing psychology to benefit society and improve people’s lives

 

 

[#DIV28SUPER] FW: NIAAA Leadership Position

Dear Colleague,

I’m writing to you on behalf of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) about an exciting opportunity.  The vacancy announcement for the position of Deputy Director, NNIAAA) is now open.  We are conducting a search open to all qualified candidates, and welcome your assistance in sharing the information with potential candidates whom you feel could provide the leadership and professional excellence required for this position. 

 

A description of the position, qualification requirements, and application procedures are outlined in the vacancy announcement posted to the NIH Executive Careers page using the following link:  

 

Deputy Director, NIAAA

 

Applications must be received by February 21, 2017, 11:59 PM, ET. 

 

If you or any candidates have questions about the position, please refer them to me.   Technical questions regarding application procedures may be addressed to Ms. Mariela Light at:  SeniorRe@od.nih.gov  or by calling 301-496-9788.

 

Warmest regards,

Wilson Compton

Chair, Search Committee for NIAAA Deputy Director

 

Wilson M. Compton, M.D., M.P.E.

Deputy Director

National Institute on Drug Abuse

National Institutes of Health

U.S. Department of Health and Human Services

Bethesda, Maryland, USA

P:  301-443-6480

E:  wcompton@nida.nih.gov

 

[#DIV28SUPER] Assistant Professor position in Behavioral Neuroscience at Kansas State University

Kansas State University: ASSISTANT PROFESSOR IN BEHAVIORAL NEUROSCIENCE. The Department of Psychological Sciences at Kansas State University expects to fill a tenure-track position at the assistant professor level in the Department’s Behavioral Neuroscience area to begin August 2017. The Behavioral Neuroscience area is part of a research-based Ph.D.-granting department in which faculty members conduct research, supervise graduate students, and teach two courses (graduate and/or undergraduate) each semester. A strong record of publication, demonstrated excellence in teaching, and the ability to develop a funded research program are required.

 

The Department of Psychological Sciences, which is part of the College of Arts and Sciences, has 15 full-time faculty members who are active researchers and also serve more than 500 undergraduate majors, many of whom are involved in research.  The Department has an extensive Ph.D. program with four major areas: Behavioral Neuroscience, Cognitive, Industrial/Organizational, and Social. The department’s Graduate Teaching Apprenticeship program prepares doctoral students to teach in higher education and is one of the few of its type in the country. Additional details about the department are available at: http://www.k-state.edu/psych.

Psychological Sciences | Kansas State University www.k-state.edu Department of Psychological Sciences Kansas State University 492 Bluemont Hall 1114 Mid-Campus Dr North Manhattan, Kansas 66506-5302. 785-532-6850 785-532-5401 fax

 

 

Kansas State University is a Land Grant University, designated as a Carnegie Doctoral/Research-Intensive Institution, and has been ranked among the top state and private institutions of higher education in numbers of Rhodes, Marshall, Truman, Goldwater, and Udall scholars since 1986. Current enrollment is over 23,000 students. Kansas State University has been selected as the home of the National Bio and Agro-Defense Facility (NBAF); this $1.5 billion research facility will provide research infrastructure to protect the country’s food supply and agriculture economy.

 

Kansas State University is located in Manhattan, a progressive university community with a metropolitan population of over 110,000, which is located in the scenic Flint Hills of Northeast Kansas (see www.manhattan.org). The community offers a friendly and safe environment. It also features excellent housing, outstanding schools, excellent parks and recreation facilities, a wide variety of shopping and dining establishments, and short commute times.

 

The successful candidate should demonstrate a strong commitment to teaching and mentoring of students and to serving a diverse population. A doctoral degree in Psychology or a neuroscience-related field is required prior to the time of appointment. Postdoctoral experience is desirable. Applicants should apply online and submit a curriculum vita, statements of research and teaching interests, three representative publications, and the names and contact information for three references:  http://careers.k-state.edu/cw/en-us/job/500284/assistant-professor. Review of applications will begin on February 15, 2017 and will continue until the position is filled. Inquiries can be addressed to Stephen W. Kiefer, Department of Psychological Sciences, Kansas State University, Manhattan, KS 66506. (swkiefer@ksu.edu). In connection with your application for employment, Kansas State University may procure a Background Screen on you as part of the process of considering your candidacy as an employee. Kansas State University is an Equal Opportunity employer and actively seeks diversity among its employees.

 

____________________________

Mary E. Cain, PhD

Professor

Kansas State University

Department of Psychological Sciences

418 Bluemont Hall

Manhattan, KS 66506

[#DIV28SUPER] Reminder: Journal of Studies on Alcohol and Drugs Special Section on Mechanisms of Behavior Change - Call for Papers!

Dear friends and colleagues,

 

Happy New Year!  A quick reminder about our Call for Papers for a special section of the Journal of Studies on Alcohol and Drugs devoted to the study mechanisms of behavior change in alcohol and drug use disorders. All submissions will undergo peer review. Manuscripts received by April 1, 2017 will be considered for inclusion in the special section.

 

We strongly encourage individuals to contact us in advance with ideas by sending a Letter of Intent with draft title and abstract by January 15, 2017 to the Special Section Guest Editors: Molly Magill molly_magill@brown.edu and Katie Witkiewitz katiew@unm.edu.

 

Sincerely,

Katie Witkiewitz

On Behalf of the Mechanisms of Behavior Change RSA Satellite Session Planning Committee (NIAAA U13AA024013)

 

 

Katie Witkiewitz, PhD

President, Society of Addiction Psychology (APA Division 50)

Associate Professor

Department of Psychology

Center on Alcoholism, Substance Abuse, and Addictions

MSC03-2220

University of New Mexico

Albuquerque NM 87131

Office phone: 505-277-5953

Vmail: 505-925-2334

Fax: 505-277-1394

http://casaa.unm.edu/kwitkiewitz.html

 

[#DIV28SUPER] UCSF Postdoctoral Traineeship in Drug Abuse Treatment and Services Recruitment

 

Postdoctoral Traineeship in Drug Abuse Treatment and Services

Research Training Program

University of California, San Francisco

 

The Substance Abuse Research Program at the University of California, San Francisco is currently accepting applications to its two-year postdoctoral research training program.  This program, funded by a National Institute on Drug Abuse (NIDA) T32 grant, aims to produce the next generation of leaders in the field of drug abuse treatment and services research.  With the support of faculty mentors, scholars design and implement studies on treatment of drug dependence.  Current research interests of faculty include trials of efficacy and effectiveness of psychosocial and pharmacologic treatment of drug abuse, including:

 

§  Tobacco dependence and food insecurity

§  Innovative methodology including Internet-based studies

§  Treatment of complex patients in innovative settings

§  Diagnostic techniques and research on treatment tailored for HIV-positive drug abusers and drug abusers with psychiatric and medical disorders

§  Provision of services to drug abusing populations

§  Instrument development in drug abuse
 

A variety of university-affiliated and community substance abuse programs are available as research sites. These include inpatient and outpatient setting programs that treat a range of problems related to drugs of abuse, including dependence on cocaine, nicotine, alcohol, and opiates. Our program encourages close research involvement with your preceptor, and involvement in selected classes, seminars, and grant preparation.  Resources from other significant extramural funding and R01-level grants are also routinely available to scholars.  Funds for travel and training opportunities are available.

More information can be found at:

http://psych.ucsf.edu/DATSRTP

 

Positions with start dates for July 1, 2017 are available.

 

To Apply: Submit a cover letter stating your research interests along with CV, representative work or dissertation chapters, and 2 letters of reference to: Rebecca.cook@ucsf.edu.  Applicants must have completed their doctoral degree and be a U.S. citizen or have Lawful Permanent Residency (green card) status at the time of appointment.

 

 

Rebecca Cook, Division Administrator

Substance Abuse Research Program

ZSFG Psychiatry, UCSF School of Medicine

Rebecca.cook@ucsf.edu

(415) 206-3051

 

James L. Sorensen

Professor of Psychiatry

UCSF Department of Psychiatry at San Francisco General Hospital

Substance Abuse Research Program

Interim Director, Div. of Substance Abuse and Addiction Medicine

Zuckerberg San Francisco General Hospital and Trauma Center

1001 Potrero Avenue

SFGH Building 20, Rm. 2117

San Francisco, CA 94110

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28M] FW: Doing research on opioids?

Dear Division 28 Members-
Please see the email string below looking for experts on evidence-based opioid treatments to contribute to an APA Monitor on Psychology article. If you can help, please email the author, Kirsten Weir, directly at kw@kirstenweir.com
Thanks and happy new year!
-Bill Stoops.

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684

Associate Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
Component Lead
Research Methods
University of Kentucky Center for Clinical and Translational Science

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

---

From: apadiv50-forum-bounces@mailman.yale.edu [apadiv50-forum-bounces@mailman.yale.edu] on behalf of Bruce Liese [BLIESE@kumc.edu]
Sent: Wednesday, January 04, 2017 9:41 AM
To: Apadiv50-forum@mailman.yale.edu
Cc: kw@kirstenweir.com
Subject: [Apadiv50-forum] Doing research on opioids?

Hello SoAP friends,

Happy New Year!

I've received the email, copied below, from Kirsten Weir. She is writing an article on opioids for the APA Monitor and would like some expert input. Please contact her directly if this is your area of expertise.

Warm regards,

Bruce

Bruce S. Liese, Ph.D., A.B.P.P.
President-Elect, APA Division 50 (Addictions)
Professor of Family Medicine and Psychiatry
Courtesy Professor of Clinical Psychology
University of Kansas
3901 Rainbow Blvd.  Mailstop 4010
Kansas City, Kansas 66160
bliese@kumc.edu
913-588-1912

____________________________

Hi Dr. Liese,

I'm a contributing writer for the Monitor on Psychology, APA's monthly magazine for members. I'm working on an article about opioid dependence and research-based interventions for treating opioid addiction. I was hoping that you might recommend some Div. 50 colleagues who are doing research in this area? Please let me know if anyone stands out as important players in this space. Many thanks! 

Best,

Kirsten

Kirsten Weir 

Writer & Editor

Science * Health * Psychology
(612) 990-9245 * kw@kirstenweir.com

Learn more at kirstenweir.com